| Steven Tuong, PHARMD | |
|
20711 Bothell Everett Hwy, Bothell, WA 98012-7139 | |
| (425) 486-4473 | |
| (425) 485-0725 |
| Full Name | Steven Tuong |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 20711 Bothell Everett Hwy, Bothell, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366177222 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH61292936 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Steven Tuong, PHARMD 20711 Bothell Everett Hwy, Bothell, WA 98012-7139 Ph: (425) 486-4473 | Steven Tuong, PHARMD 20711 Bothell Everett Hwy, Bothell, WA 98012-7139 Ph: (425) 486-4473 |
News Archive
An innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies, report scientists from Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, and Children's Hospital Boston.
Liberator Medical Holdings, Inc. today announced its wholly owned subsidiary, Liberator Medical Supply, has received the 2010 Governor's Business Diversification Award in the Business Expansion category.
A pioneering approach to imaging breast cancer in mice has revealed new clues about why the human immune system often fails to attack tumors and keep cancer in check. This observation, by scientists at the University of California, San Francisco (UCSF), may help to reveal new approaches to cancer immunotherapy.
A recent study discusses variations in the hospitalization and mortality rates due to SARS-CoV-2 infection among rural and urban regions in the U.S.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
› Verified 9 days ago
Linda-ruby C Jacobson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11913 Ne 195th St, Bothell, WA 98011 Phone: 425-489-3100 | |
Michelle Taylor, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3530 214th Pl Se, Bothell, WA 98021 Phone: 425-218-8812 | |
Minh Thao Hoang Luong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20812 Bothell Everett Hwy, Bothell, WA 98021 Phone: 425-398-0204 | |
Noriko Ono, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22631 Bothell Everett Hwy, Bothell, WA 98021 Phone: 425-481-8771 Fax: 425-402-0650 | |
Seung H Shin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21540 30th Dr Se Ste 220, Bothell, WA 98021 Phone: 206-341-0640 Fax: 206-341-0648 | |
Christina Anwar Girgis, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20812 Bothell Everett Hwy, Bothell, WA 98021 Phone: 425-398-0204 Fax: 425-481-7845 | |
David Lynn Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21540 30th Dr Se Ste 400, Bothell, WA 98021 Phone: 425-424-7140 |